AI-generated summary
The authors studied aged mice given anesthesia and surgery to model perioperative neurocognitive disorder, then treated them with transcranial near-infrared light at 810 nm for two weeks. They report that cognitive impairment and mitochondrial dysfunction were ameliorated, with improved synapse-related protein expression and neuronal survival, linked to the SIRT1/PGC-1α pathway. These findings come from an animal study only.
- Who or what was studied
- Aged male C57BL/6 mice (18 months) used to model perioperative neurocognitive disorder
- Wavelengths
- 810 nm
- Limits stated in the abstract
- The study was conducted in mice only, so the findings may not apply to humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Transcranial photobiomodulation, Near-infrared, Mitochondria, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.